SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
NORO-MOSELEY PARTNERS VI, L.P.

(Last) (First) (Middle)
4200 NORTHSIDE PARKWAY, N.W.
BUILDING 9

(Street)
ATLANTA GA 30327

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/16/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A 0% Convertible Preferred Stock $0 08/16/2012 P 986,854 08/16/2012 (1) COMMON STOCK 986,854 $3 986,854 I SEE EXPLANATION OF RESPONSE BELOW(3)(4)
Warrants $3.99 08/16/2012 P 490,000 02/17/2013 02/17/2018 COMMON STOCK 490,000 $0(2) 490,000 I SEE EXPLANATION OF RESPONSE BELOW(3)(4)
1. Name and Address of Reporting Person*
NORO-MOSELEY PARTNERS VI, L.P.

(Last) (First) (Middle)
4200 NORTHSIDE PARKWAY, N.W.
BUILDING 9

(Street)
ATLANTA GA 30327

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Moseley & Co VI, LLC

(Last) (First) (Middle)
4200 NORTHSIDE PARKWAY, N.W.
BUILDING 9

(Street)
ATLANTA GA 30327

(City) (State) (Zip)
Explanation of Responses:
1. The Series A 0% Convertible Preferred stock is convertible at any time and has no expiration date.
2. No consideration was paid to acquire the warrants.
3. Report filed jointly by Noro-Moseley Partners VI, L.P. and its general partner, Moseley and Company VI, LLC.
4. The foregoing securities are owned directly by Noro-Moseley Partners VI, L.P. Moseley and Company VI, LLC may be deemed to beneficially own all of the foregoing securities.
Allen Moseley, AS CLASS A MEMBER OF EACH REPORTING ENTITY 08/20/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.